Shine Investment Advisory Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Shine Investment Advisory Services’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$3K	Sell	6 -3	-33%	-$1.82K	﹤0.01%	680
2020 Q2	$6K	Sell	9 -2	-18%	-$1.14K	﹤0.01%	619
2020 Q1	$5K	Buy	+11	New	+$4.54K	﹤0.01%	614
2019 Q2	–	Sell	-298	Closed	-$122K	–	710
2019 Q1	$122K	Hold	298	–	–	0.06%	153
2018 Q4	$111K	Buy	298 +152	+104%	+$55.6K	0.05%	157
2018 Q3	$59K	Buy	+146	New	+$55.6K	0.03%	274

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Shine Investment Advisory Services's REGN Position: Q3 2020 in Review

Shine Investment Advisory Services reduced its Regeneron Pharmaceuticals (REGN) stake by 33% in Q3 2020, selling an estimated $1.82K and leaving 6 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #680.

Shine Investment Advisory Services first reported a position in REGN in Q3 2018 and has held it in 6 quarters since. The position peaked at $122K in Q1 2019. 908 funds tracked by Wall St. Rank hold REGN as of Q3 2020.

Shine Investment Advisory Services held 6 shares of Regeneron Pharmaceuticals worth $3K as of Q3 2020.
Shine Investment Advisory Services sold 3 Regeneron Pharmaceuticals shares in Q3 2020, an estimated $1.82K.
Regeneron Pharmaceuticals made up ﹤0.01% of Shine Investment Advisory Services's portfolio in Q3 2020, its #680 holding.
Shine Investment Advisory Services first reported a position in Regeneron Pharmaceuticals in Q3 2018 and has held it in 6 quarters since.
Shine Investment Advisory Services's Regeneron Pharmaceuticals position peaked at $122K in Q1 2019.
908 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2020.

Based on Shine Investment Advisory Services's 13F filing for Q3 2020, filed 3 Nov 2020.